Plunkett Research Online: Incyte Corporation

INCYTE CORPORATION (INCY:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly).....



Incyte Corporation
Ticker: INCY
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 302 498-6700
Fax: 302 425-2750
Address: 1801 Augustine Cut-Off
Wilmington, DE 19803 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Discovery & Development
Drug Development
Drug Research
Drug Discovery
Biopharmaceuticals
Contacts Description
Herve HoppenotCEO/Chairman of the Board/Director/President
Christiana StamoulisCFO/Executive VP
See More
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly).....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
JAKAFI
ICLUSIG
Pemazyre
Monjuvi
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors:

Incyte offers comprehensive benefits and retirement plans.